Navigation Links


Dynamics in Medical Technology

Impulse Dynamics Announces Pivotal Results at the American College of Cardiology Annual Meeting Late-Breaking Session

... ORLANDO, Fla., March 29 /PRNewswire/ -- Impulse dynamics (U.S.A.) Inc. announced today findings from the ... initiating a new contraction. About Impulse dynamics Impulse dynamics is focused on the development of electrical ...

New Study Shows Cloning from Dried Cells Now Possible

... MT. LAUREL, N.J., Sept. 8 /PRNewswire/ -- Core dynamics Inc. today announced that cloning with ... for clinical use." About Core Dynamics: Core dynamics is a privately held biotechnology company that ... are located in Mt. Laurel, New Jersey. Core dynamics hopes to develop additional applications through ...

New CoMotion(R) Trials Software by General Dynamics Enables Rapid, Interactive Sharing of Real-time Data for Clinical Trials

... Ariz., April 28 /PRNewswire/ -- General dynamics Viz, a part of General dynamics C4 Systems, introduces CoMotion(R) Trials, ... product management director for General dynamics Viz. "CoMotion Trials streamlines the flow of ...

Progen Announces Commencement of Global Phase 3 Study for PI-88 in Post- Resection Liver Cancer

... USA: Robert D. Stanislaro Evan Smith Financial dynamics Financial dynamics T: 212-850-5657 T: 212-850-5606 E: ...

Progen Announces PI-88 Phase 2 Lung Cancer Results

... Media Relations USA: Robert D. Stanislaro Financial dynamics T: 212-850-5657 E: robert.stanislaro@fd.com Investor Relations USA: Evan Smith Financial dynamics T: 212-850-5606 E: evan.smith@fd.com ...

Hand Washing with 4% CHG Antiseptic Kills Flu Viruses

... and Hibistat(R) antiseptics); and BARRIER(R) protective clothing. A leader in trauma and pain management, the Wound Care Division's market dynamics are driven by an aging population, higher incidence of pressure ulcers and increased home treatment. ...

USAID Provides $5M in Emergency Support as Swine Flu Spreads

... Control and Prevention, to work with authorities in Mexico. The team will further investigate and characterize the virulence and transmission dynamics of the disease. USAID is responding to the international outbreak in coordination with the Centers for Disease Control and Prevention (CDC). To ...

First Year Results of the AXA Research Fund: Over Euro 13 Million Allocated for Research in 2008

... impact of climate change on major flooding in Europe (Institute for Meteorology in Berlin) Project dedicated to the study of the impact and dynamics of marine aliens in the context of climate change (Queen's University Belfast) Project dedicated to assessing civil conflict risks ...

A First-Line Therapy for Renal Cell Carcinoma that can Increase Overall Survival when Compared with Sutent Would Earn a Higher Patient Share in the United States Than in Europe

... DecisionBase 2009 is a decision-support tool that provides in-depth analysis of unmet need, physician expectations of new therapies and commercial dynamics to help pharmaceutical companies optimize their investments in drug development. The report can be purchased by contacting Decision Resources. ...

Angiomax Will Retain Decision Resources' Proprietary Clinical Gold Standard Status Over Current and New Therapies, Including Recently-Approved Efient, for the Treatment of NSTEMI

... DecisionBase 2009 is a decision-support tool that provides in-depth analysis of unmet need, physician expectations of new therapies and commercial dynamics to help pharmaceutical companies optimize their investments in drug development. The report can be purchased by contacting Decision Resources. ...

Indevus Pharmaceuticals Announces PRO 2000 Found to Show Promise in Large HIV Prevention Study

... on condoms or abstinence as methods for protecting themselves from HIV. Even a partially effective microbicide could have a profound impact on the dynamics of HIV transmission. According to mathematical modeling conducted by the London School of Hygiene and Tropical Medicine, 2.5 million HIV infections ...

Biotica Strikes Significant Collaboration Deal With GlaxoSmithKline

... Enquiries Biotica Technology Ltd Tel: +44-1799-532920 Dr Edward E. Hodgkin, CEO enquiries@biotica.com Financial dynamics Tel: +44(0)20-7831-3113 Ben Atwell Ben.Atwell@fd.com ...

Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand

... Isogen can ramp follow-on funding to expand its presence in the biopharma industry. "Isogen will help our customers address major industry dynamics that are reshaping the face and complexity of sterile clinical trials materials supply," said Edwards. "Regulators in the U.S. and Europe ...

Elsevier is Expanding eClinical Solutions in Europe

... throughout their workday." Capturing 'e' Opportunities Elsevier is uniquely positioned to replicate its success in the U.S. abroad. Market dynamics are different, as European E-Health markets and Elsevier's positions within them are at an earlier stage of development than in the U.S. However, key ...

GeneGo is Awarded NCI Grant for Development of Systems Biology Platform for Integrative Data Analysis in Cancer

... in terms of gain and loss of functions. We need to understand in a database structure the causal relationships between the involved pathways and the dynamics of pathway activation during tumorigenesis. These are two main goals of the MetaMiner project." "There are many 'generic' pathway tools on the ...

Discovering How Video Games Can Motivate Healthy Behaviors: More than $2 Million Awarded to 12 Research Teams Across U.S.

... time, players' amount, type and enjoyment of physical activity, quality of life, body mass index and body composition. It also will examine family dynamics in the activities they do together and factors that influence their motivation to be physically active. Union College, Department of Psychology ...

Top Academic Medical Centers, Research Institutions, and Partners Gather, Share Experiences and Success Stories at Velos eResearch Annual Meeting

... Executive Vice President. "These Velos customers have the knowledge, resources, and incentive to facilitate positive change. We've witnessed these dynamics in action this week here in San Francisco." About Velos Velos is the trusted clinical trial management resource for investigators, sponsors and ...

Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results

... to joining Neurocrine, Mr. Beck held financial management positions at various high technology and financial services companies, including General dynamics and Ernst and Young LLP. Mr. Beck received a B.A. in accounting from the University of Washington and also holds a Th.B. in theology from a Seattle, ...

Pharsight Invited to Present on HIV Modeling and Simulation at ASCPT Annual Meeting

... Dr. Poland's presentation, entitled "Using in Vitro and Literature Data to Predict Effects of New Anti-Retrovirals", will describe how PK/PD-viral dynamics models developed using preclinical data and literature data on existing HIV treatments can inform dose-response predictions for new anti-retroviral ...

Phosphagenics Initiates U.S. Clinical Trials for Its Topical Retinoic Acid

... U.S. Investor and Media Contacts: Harry Rosen Brian Ritchie Phosphagenics Limited Financial dynamics President and CEO Tel +1 212 850 5683 Tel +61 3 9605 5900 Mary McSwiggan Phosphagenics Limited Investor Relations Manager ...

West Pharmaceutical Services, Inc. Appoints New Director

... Japan, Asia and Australia. Contacts: Investors and Financial Media: West Pharmaceutical Services, Inc. Financial dynamics Michael A. Anderson Evan Smith/Theresa Kelleher Vice President and Treasurer (212) 850-5600 (610) 594-3345 ...

KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model

... of Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's disease). KM-801 is a small-molecule agent, which has been shown to alter microtubule dynamics in nerve cells in preclinical studies (J Biol Chem. 2007 Jun 13). KineMed researchers have discovered that patients with ALS have more rapid rates ...

Molnlycke Drives 'Home' the Fight Against Staph and Other MRSA Infections

... and Hibistat(R) antiseptics); and BARRIER(R) protective clothing. A leader in trauma and pain management, the Wound Care Division's market dynamics are driven by an aging population, higher incidence of pressure ulcers and increased home treatment. (1) Bell, Edward A. "Antibiotic Choices for ...

New Study Reveals Limitations of a Complex and Challenging Global Tuberculosis Drug Marketplace

... First comprehensive study of market dynamics offers insights into what will be needed to get ... results from the first comprehensive study of the dynamics of the global TB drug market that offers a ... The study, Pathway to Patients: Charting the dynamics of the Global TB Drug Market, reveals the ...

CeNeS Pharmaceuticals plc: Update on Successful Phase III results announced on Lead Product M6G

... please contact: CeNeS Pharmaceuticals plc Neil Clark, CEO Tel: +44 (0)1223 266 466 JM Finn Geoff Nash Tel: +44(0) 207 628 9688 Financial dynamics Ben Brewerton/Emma Thompson Tel: + 44 (0) 207 831 3113 About CeNeS Pharmaceuticals CeNeS is a biopharmaceutical company specialising in the ...

EntreMed Presents Mechanism Data for Its Three Lead Oncology Compounds

... of our three lead compounds, yet clinical and preclinical data for these product candidates demonstrate that subtle differences in microtubule dynamics can lead to different approaches to the treatment of cancer. Panzem(R), MKC-1 and ENMD-1198 are all orally-active yet distinct tubulin ...

CeNeS Pharmaceuticals Plc Announces Preliminary Results for The Year Ending 31 December 2006

... please contact: CeNeS Pharmaceuticals plc Neil Clark, CEO Tel: +44 (0)1223 266 466 JM Finn Geoff Nash Tel: +44(0) 207 628 9688 Financial dynamics Ben Brewerton/Emma Thompson Tel: + 44 (0) 207 831 3113 About CeNeS Pharmaceuticals CeNeS is a biopharmaceutical company specialising in the ...

Cytokinetics Announces Non-clinical Data to be Presented at the 2007 AACR Annual Meeting

... as peripheral neuropathy, an impairment of peripheral nervous system function. Neuropathies are thought to result when these drugs interfere with the dynamics of microtubule filaments that are responsible for the long-distance transport of important cellular components within nerve cells. Mitotic kinesins ...

Vertex Pharmaceuticals Announces New Data for Investigational HCV Protease Inhibitor Telaprevir to be Presented at 42nd Annual Meeting of the European Association for the Study of the Liver (EASL)

... Viral Decline During Telaprevir (VX-950) and Peg-IFN Combination Treatment Predicted by a New Combined Intracellular and Cellular Hepatitis C Viral dynamics Model," will be presented by A.U. Neumann of Bar-llan University, Israel. -- "Telaprevir (VX-950)-Resistant Variants Exhibit Reduced Replication ...

EntreMed Presents Multi-Mechanism Antitumor Data for ENMD-1420 in Preclinical Models

... tubulin protein, either in the monomer form or polymerized in microtubules, and prevent cancer cell proliferation by interfering with the microtubule dynamics required for cell division. This interference blocks the cell cycle sequence, leading to cell death (apoptosis). About EntreMed EntreMed, Inc. is ...

Telomerase Presentations at the AACR 2007 Annual Meeting

... to form aggressive tumors. Information in Dr. DePinho's talk and other presentations throughout the AACR meeting on the regulation of telomere dynamics and telomerase activity elucidates the potential for telomerase-inhibiting molecules in the treatment of cancer. Cancer Stem Cells Cancer stem ...

Independent publication supports the profile of CeNeS phase II compound, CNS 5161

... please contact: CeNeS Pharmaceuticals plc Neil Clark, CEO Tel: +44 (0)1223 266 466 JM Finn Geoff Nash Tel: +44(0) 207 628 9688 Financial dynamics Ben Brewerton/Emma Thompson Tel: + 44 (0) 207 831 3113 About CeNeS Pharmaceuticals CeNeS is a biopharmaceutical company specialising in the ...

FDA approves IND on Lead Product M6G

... please contact: CeNeS Pharmaceuticals plc Neil Clark, CEO Tel: +44 (0)1223 266 466 JM Finn Geoff Nash Tel: +44(0) 207 628 9688 Financial dynamics Ben Brewerton/Emma Thompson Tel: + 44 (0) 207 831 3113 About CeNeS Pharmaceuticals CeNeS is a biopharmaceutical company specialising in the ...

Further Statistical Analysis of the Recent Phase III trial on Lead Product M6G Shows Additional Benefits

... please contact: CeNeS Pharmaceuticals plc Neil Clark, CEO Tel: +44 (0)1223 266 466 JM Finn Geoff Nash Tel: +44(0) 207 628 9688 Financial dynamics Ben Brewerton/Emma Thompson Tel: + 44 (0) 207 831 3113 About CeNeS Pharmaceuticals CeNeS is a biopharmaceutical company specialising in the ...

Cytokinetics Reports Additional Clinical Trials Data for Ispinesib

... peripheral neuropathy, an impairment of peripheral nervous system function. Neuropathies are thought to result when these drugs interfere with the dynamics of microtubule filaments that are responsible for the long-distance transport of important cellular components within nerve cells. Mitotic kinesins ...

Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme

... please contact: CeNeS Pharmaceuticals plc Neil Clark, CEO Tel: +44 (0)1223 266 466 JM Finn Geoff Nash Tel: +44(0) 207 628 9688 Financial dynamics Ben Brewerton/Emma Thompson Tel: + 44 (0) 207 831 3113 About CeNeS Pharmaceuticals CeNeS is a biopharmaceutical company specialising in the ...
Other Contentsgiantgiantgiantgiantgiantgiantgiantgiardiasisgingivagingivitisgingivitisgingivostomatitisglomerulonephritisglaucomaglaucomaglaucoma
(Date:11/25/2009)... in the stomach, may be used to boost resistance t..., Yale School of Medicine researchers report in a ...of Neuroscience . , Parkinson,s disease is cause... of the midbrain known as the substantia nigra, wh...ed production of dopamine in late-stage Parkinson,...
(Date:11/25/2009)...f the Cell Death Research Laboratory in the Univer...arded the prestigious Johnson & Johnson Focused Fu...f brain cell damage in Parkinson,s disease. The aw...upport of innovation and excellence in science, wa...ier this month at an event at the Hyatt Regency Ho...
(Date:11/25/2009)...ssistant professors recently received funding from... research beneficial to understanding the environm...her Blackwood, assistant professor in the Departme...upport two separate research projects. , His fir...ommunities and Functions from the Leaf to the Land...
Breaking Biology News(10 mins):Hormone ghrelin can boost resistance to Parkinson's disease 2Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Kent State University professors focus research on the environment with grants totaling $890,000 2Uninsured Patients to Receive Free Surgeries Procedures 54795 1Uninsured Patients to Receive Free Surgeries Procedures 54795 2Uninsured Patients to Receive Free Surgeries Procedures 54795 3Uninsured Patients to Receive Free Surgeries Procedures 54795 4Hospitals Reduce Heart Attack Deaths 54790 1Hospitals Reduce Heart Attack Deaths 54790 2Hospitals Reduce Heart Attack Deaths 54790 3FidoDogTreats com Launches Veterinarian Directory 54786 1FidoDogTreats com Launches Veterinarian Directory 54786 2
(Date:11/25/2009)...serious behavior problems that can occur in childr...ed with a treatment plan that includes medication ...rents, according to Yale University researchers an... 2009 issue of the Journal of the American Academ...as conducted by the National Institute of Mental H...
(Date:11/25/2009)...found puffs of air on flesh that mimicked parts of... WEDNESDAY, Nov. 25 (HealthDay News) -- People can...eir skin, new research shows. , In fact, sensat...f speech actually helped people decipher sounds be... never been able to show whether we could use tact...
(Date:11/25/2009)... Initiative expands to include ...students, teachers, and healthcare professionals i...asanton, CA (PRWEB) November 25, 2009 -- Ellumina...cial networking solutions that support 21st centu...d today that its Fire and Ice initiative was awa...
(Date:11/25/2009)..., WASHINGTON,Nov.25/PRNewswire-FirstCall/--TheAdvi...twillparticipateinthe21stAnnualPiperJaffrayHealthC...,onDecember2,2009at3:00PM(EST),willbetheCompany,sC...pany,sChiefFinancialOfficer,MichaelT.Kirshbaum.The...website,foundat http://www.advisoryboardcompany.co...
(Date:11/25/2009)..., MT.CLEMENS,Mich.,Nov.25/PRNewswire/--TwomoreH1N1...dSaturday,Dec.5,theMacombCountyHealthDepartmentann...keplaceatFreedomHillCountyParkinSterlingHeights. ,...c.5onewillrunfrom9a.m.to3p.m.Thethimerosol-freever...st,whilesupplieslast.Bothinjectableandnasalsprayim...
Breaking Medicine News(10 mins):Health News:Parent training key to improved treatment of behavior problems in children with autism 2Health News:Your Skin Can Help Your Ears Listen 2Health News:Your Skin Can Help Your Ears Listen 3Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 2Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 3Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 4Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 5Health News:Macomb County Health Department Schedules Two More H1N1 Flu Vaccine Clinics Dec. 3 and 5 2
Other TagsPortionAffectedPermanentReceptorsSwitzerlandOther Tagspink 2teach 2teach 3teach 4teach 5teach 6mitochondrial 2mitochondrial 3apoptosis 2apoptosis 3orange 2acidity 2general 2general 3general 4general 5general 6general 7general 8general 9general 10